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Neuropsychiatric Public Policy
Complications of Implications
HIV Infection:
Alexandra Beckett, M.D.
Theo Manschreck, M.D.
The human immunodeficiency virus (HIV) infects the central nervous system (CNS), caus-
ing symptoms in mostpersons with AIDS-related complex (ARC) and AIDS, and in a sig-
nificantproportion ofthose classified as asymptomatic seropositive. The most common
clinical syndrome secondary to CNS infection is known as HIV encephalopathy. When
sufficiently disabling, HIV encephalopathy is known as AIDS dementia, and must be
reported to the Centersfor Disease Control as a case ofAIDS.
AIDS dementia is a complex ofcognitive, affective, behavioral, and motor symptoms
which varies widely in its presentation. In some persons, cognitive impairmentpredomi-
nates, manifesting in a loss ofintellectual capacities such as short-term memory, informa-
tion processing, and abstract thinking. When mood disturbance predominates , it may
present as irritability, anxiety, depression, or mania. Behavioral complications are most
often due to confusion orpsychosis, and may render the patient difficultfor caretakers
to manage. Motor impairments include slowing, gait abnormalities , incontinence, and
paralysis.
AIDS dementia presents a significant challenge to the public health system. Physicians,
other health providers, andpolicymakers must be educated so that they may tackle the
problems ofdiagnosis, acute and chronic care, andpublic safety which are related to this
illness.
AIDS is one of a spectrum of disorders resulting from infection by the human im-
munodeficiency virus (HIV). In addition to AIDS, there exists a number of syn-
dromes of immune dysfunction, such as AIDS-related complex (ARC). Furthermore, it
has been established that HIV causes serious neurological dysfunction in most AIDS
patients, in a significant number of persons with ARC, 1 in some otherwise asymptomatic
seropositives, and occasionally in persons with a false-negative serologic test. 2 3
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Neurological Disorders: Phenomenology
Substantial evidence indicates that HIV infects the nervous system. HIV has been recov-
ered from brain, cerebrospinal fluid, spinal cord, and peripheral nerve of patients with
HIV infection and neurological disease. Over 90 percent of autopsied AIDS cases have
histopathological changes in the brain. 4
Sixty-three percent of AIDS patients have neurological symptoms during the course of
their illness, and in 20 percent, these symptoms are the initial chief complaint leading to
the AIDS diagnosis. 5 All levels of the nervous system may be affected, but cerebral in-
volvement is the most common. Many factors may adversely affect neurological function
in persons with an HIV infection, including prior neuropsychiatric disorders, concurrent
drug treatment, systemic illness, malignancies (both primary and metastatic to the central
nervous system), and opportunistic infections.
Infections afflicting immunocompromised hosts include bacterial, fungal, and viral
types. The infectious agent most likely to impair nervous system function in an HIV-in-
fected host is HIV itself. Many HIV-induced disorders, affecting each level of the nervous
system, have been described. 6 In the peripheral nervous system, nerve palsies may pro-
duce painful sensory disturbance or motor weakness, or both. Autonomic neuropathy
resulting in postural hypotension, with symptoms such as dizziness, is also frequently
present. Damage to the spinal cord occurs in as many as 30 percent of AIDS patients,
with consequent gait problems and urinary incontinence. 7
The most common HIY-related disorder in the nervous system is known variously as
nonfocal encephalopathy, subacute encephalitis, or AIDS dementia complex. 8 It is suffi-
ciently prevalent that the Centers for Disease Control (CDC) recorded cases ofAIDS
dementia among its AIDS statistics as of September 1 , 1987. Notably, the dementia may
occur in the absence of concomitant immune disease; that is, in otherwise relatively
symptom-free HIV-infected persons.
AIDS dementia is a complex of cognitive, affective, behavioral, and motor abnormali-
ties. It usually begins with subtle alterations in mental status, such as poor concentration
and mild, short-term memory loss. Patients may complain of forgetfulness, confusion,
and mental slowing. Owing to attentional lapses, they may lose the train of a conversation
or be unable to follow an entire television program or read a book.
Affective symptoms often include anxiety and severe depression, with loss of energy,
diminished appetite, and sleep disturbance. Patients with these symptoms may be apa-
thetic, socially withdrawn, mildly irritable, or inappropriate in their behavior. At times,
behavioral changes may be more dramatic, marked by acute psychosis with agitation,
hallucinations, paranoid ideation, and even mania.
Motor impairments are common and may include lower extremity weakness, ataxia,
tremors, and difficulty with articulation. Patients may notice unsteadiness when walking,
deterioration in handwriting, or slightly slurred speech.
The course of AIDS dementia is variable. In some individuals, it is indolent and slowly
progressive. Concentration and memory may worsen, but individuals continue to work
and live independently. In others, the course of AIDS dementia is rapid and catastrophic,
progressing in a matter of weeks or months to severe intellectual deterioration, marked
psychomotor slowing, and mutism. Hyperreflexia, urinary and fecal incontinence, and,
occasionally, seizures may occur.
Because the HIV-infected individual is vulnerable to numerous influences that can
manifest in a disturbance of mental functioning, the advent of a change in mental status in
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such a patient mandates a thorough evaluation to identify treatable causes such as tumors,
opportunistic infections, drug toxicity, or metabolic imbalances. Once these have been
ruled out, one is left with a diagnosis of AIDS dementia. There is no test that confirms the
diagnosis, making it a diagnosis of exclusion.
As mentioned, the CDC now solicits reports of HIV encephalopathy/dementia, defined
as follows: "clinical findings of disabling cognitive and/or motor dysfunction interfering
with occupation or activities of daily living, or loss of behavioral developmental mile-
stones affecting a child, progressing over weeks to months, in the absence of a concurrent
illness or condition other than HIV infection that could explain the findings." 9 The ap-
pearance of this syndrome in an HIV-infected individual is now AIDS-defining; that is, its
occurrence makes it a reportable case of AIDS.
The definition is necessarily vague, because the syndrome itself may have diverse mani-
festations, appearing singly or concurrently. In any one patient, motor, cognitive, affec-
tive, or behavioral features may predominate. Without a unique and predictable course,
current knowledge prohibits the making of precise prognoses.
AIDS Dementia Complex: Epidemiology
We do not know the incidence ofAIDS dementia. It is well known that most AIDS patients
are grossly demented at the time of death; often, this mental decline declares itself dra-
matically in the last days or weeks of life. Less well known is the extent to which these
same patients were functionally impaired prior to detection. This pattern is particularly
apt to occur when more acute medical complications dominate the clinical picture.
Careful neuropsychological assessments of seropositives and persons with AIDS-re-
lated complex have revealed a high incidence of subclinical cognitive dysfunction. Despite
the initial subclinical nature of the impairment, these individuals are coping with progres-
sive intellectual decline that may ultimately undermine their capacity for work and social
interaction.
Grant found a 44 percent incidence of neuropsychological impairment in otherwise
asymptomatic seropositives, 54 percent in persons diagnosed with ARC, and 87 percent
in persons with AIDS. 10 As the AIDS dementia complex becomes more widely recog-
nized, early, subtler signs of intellectual impairment which have previously gone unno-
ticed or which have been understood as "functional," that is, as a psychological reaction
to the diagnosis rather than organic in nature, will prompt earlier and more accurate diag-
nosis.
Clinical Vignette: Mr. A. , aforty-one-year-old single man, was referred to the psychiatry
clinicfor treatment ofdepression. Formerly employed as a public administrator, he had
lost hisjob because ofpoorperformance. Mr. A. had been in treatmentfor a year with a
psychotherapist who was addressing issues oflow self-esteem and social isolation.
On evaluation, Mr. A. was a slovenly, mildly obese man with a slow and somewhat
clumsy gait. His speech, though coherent and logical, was stuttering. Tearfully, Mr. A.
described a persistent depressed mood and thoughts that others were out to get him be-
cause ofpast homosexual encounters. He admitted to intermittent suicidal ideation. He
reported increased appetite, with aforty-pound weight gain over a year, and excessive
sleep ofup tofifteen hours a day, despite which he was chronicallyfatigued.
Mr. A. was admitted to a psychiatric hospital, where treatment with antidepressant
medication was initiated. Routine psychological testing raised the question ofcognitive
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impairment. More comprehensive testing confirmed the presence ofmultiple intellectual
deficits.
His medical evaluation included a CATscan, which demonstrated cortical atrophy and
a white blood count that was well below the normal range. An HIV antibody test was posi-
tive, and a diagnosis ofAIDS dementia was made.
Mr. A. continued to suffer mental deterioration. He was unable to carefor himselfand
was placed in a chronic care hospital, where he died some months laterfrom pneumonia.
What features of this case might alert the clinician to a possibility of AIDS dementia?
Once the possibility of this diagnosis has been raised, what type of evaluation is indicated?
How can one now help the patient?
AIDS dementia should be considered when any patient presents with a new psychiatric
condition that is accompanied by cognitive deficits or neurological impairments, or both.
One must ascertain risk for HIV infection, and document its presence, if the patient con-
sents. A medical evaluation must include CAT scan or magnetic resonance imaging
(MRI), followed by lumbar puncture for analysis of cerebrospinal fluid (CSF).
The purpose of this evaluation is twofold: identification of treatable illness, such as
cryptococcal meningitis and toxoplasmosis, and confirmation of the diagnosis of AIDS
dementia. Making the diagnosis enables the physician to counsel the patient about his or
her infectiousness and intellectual limitations; facilitate the acquisition of the necessary
public assistance; and refer the patient to appropriate caretakers.
As of January 18, 1988, 51,361 cases of AIDS had been identified in the United States
(1 ,095 in Massachusetts) with 28,683 deaths. Two hundred and seventy thousand cases
are anticipated by 1991 , with 54,000 cases in that year alone. " Given an average period of
four years from infection to disease manifestation, this number of AIDS cases would
occur by 1991 even if no new transmissions of HTV were to take place. The incidence of
ARC is thought to be two to four times that of AIDS, and the number of infected persons
in the United States totals at least 1.5 million. 12 In view of the incidence of neuropsycho-
logical impairment found by Grant and others, we must confront the likelihood that thou-
sands of persons are afflicted with AIDS dementia.
AIDS Dementia Complex Treatment
Unfortunately, there is no cure for this disorder. Early experience with Azidothymidine
(AZT) in AIDS patients suggests that the drug may retard or even reverse impairments in
some individuals. Controlled trials are under way to determine whether these preliminary
findings are significant.
Since the virus is known to reside and replicate in the central nervous system (CNS),
any effective antiviral drug must cross the blood-brain barrier and achieve sufficient
levels to eradicate virus. In the absence of such penetration, the CNS could serve as a
sanctuary for HIV despite its eradication elsewhere in the body. The establishment of such
a sanctuary introduces additional risks to the patient and raises a series of policy-related
issues. The risks are the potential for the virus to break out of its sanctuary and affect
other organs; to increase damage to the central nervous system, and thereby to cognitive
abilities; and to go unnoticed or undiagnosed.
The policy implications of the sanctuary problem include at least the efficacy of new
treatments or vaccines and the potential for occupational impairment and consequent
threats to public safety, owing to cognitive problems.
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Meanwhile, such therapies as do exist are palliative, that is, they provide some sympto-
matic relief and enhance functioning but do not alter the course of the disease. They con-
sist of drugs already used for patients with medical and psychiatric disorders, and include
psychostimulants, antidepressants, and antipsychotics.
Given the limitations of our pharmacopoeia, appropriate therapy must include accurate
appraisal of cognitive and functional capacity and assistance in adapting to individual
limitations. Because of the progressive nature of the dementia complex, patients require
close follow-up. Good medical care requires a multispecialty approach that may include
infectious disease, neurology, psychiatry, neuropsychology, and social service expertise.
Public Health Issues
Education
Updated training and increased awareness concerning the neuropsychiatric consequences
of HIV are essential for an adequate response to the epidemic. The field of knowledge is
growing rapidly. Efforts to inform health professionals are especially important. Many
physicians who were trained before the AIDS epidemic feel particularly uneasy tending to
AIDS patients and may choose to refer them to persons they regard as AIDS "experts." It
will not be possible for such specialists to provide all care. Every physician must attain a
working knowledge of AIDS, making him or her prepared to provide basic care and ready
to refer to other practitioners when such referrals are appropriate.
State planning committees, as well as involvement from the private sector, labor, and
other social organizations, will be necessary to increase understanding and enroll support
for legislative and other governmental and private solutions to the needs of these patients.
Early Diagnosis
The hallmark of successful control of disease is diagnostic sophistication. In this disease,
the early manifestations may be subtle and are often in the neuropsychiatric sphere. Most
health professionals have limited familiarity with the clinical and laboratory assessments
of such impairments. The psychiatric specialty within medicine can respond to this diag-
nostic challenge but must be ready itself to accept the challenge and the central role of
psychiatry in the treatment of HIV patients.
Any change in mental status in an HIV-infected individual necessitates immediate evalu-
ation to identify treatable causes. As mentioned earlier, there are multiple possible causes
for such a change, some of which are medical emergencies requiring acute intervention.
A proper diagnostic workup may include CAT scan, lumbar puncture, and electroenceph-
alogram (EEG).
Increased Demandsfor Care
Several problems present major challenges. First, the complexities of diagnosis, infec-
tious and neuropsychiatric, require technical know-how from several specialties that are
not organized to function together in health care settings.
Second, the kinds of clinical problems that patients have after diagnosis require medical
and psychiatric input for successful management. Currently, many HIV patients are diffi-
cult to manage on a general medical ward, owing to their agitation or psychosis, or both;
because their symptoms fall into the psychiatric range, there is pressure to refer them to a
psychiatric facility. Unfortunately, neither public nor private psychiatric hospitals are
equipped to diagnose and treat emergent medical conditions in HIV patients.
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Third, HIV patients referred to public inpatient and outpatient facilities because of
neuropsychiatric disturbances could create excessive demands on these services, which
are already pressed by growing numbers of chronically ill and homeless mentally ill
patients.
Fourth, the range of clinical presentations calls for a range of services. Some individ-
uals are only mildly impaired, with ongoing needs for medical and psychiatric follow-up,
while others are functionally incapacitated, unable to work or adequately care for them-
selves. HIV-infected patients have died from undiagnosed, treatable illnesses while in
psychiatric facilities, underscoring the need for appropriate sites for evaluation and treat-
ment of such patients with neuropsychiatric symptoms. Specialized treatment centers,
home care support, and outpatient programming for individual, group, and rehabilitative
therapy represent other services that need to be part of the solution to these problems.
Clinical Vignette: Mr. D. , a twenty-six-year-old man who had been diagnosed with AIDS
four months earlier, was brought to his internist 's office by threefriends after he disrobed
in a public park. Mr. D. was extremely agitated, talking rapidly andpacing. He admitted
to auditory hallucinations and believed that God and Satan were warring within him. He
refused to cooperate with a physical examination and threatened to strike anyone who
came near him. The patient was brought to the emergency room by hospital security,
where he was placed in a locked room.
Mr. D. 's internist instructed emergency room physicians to refer Mr. D. to a psychiatric
hospitalfor treatment ofmanic psychosis. The hospital 's psychiatric unit refused Mr. D.
admission, citing the unmanageability ofhis agitation and the potentialfor violence in an
unlockedpsychiatricfacility. Mr. D. was refused admission to other general hospital and
private psychiatric units.
Mr. D. was sent to a state mental hospital, where he was placed in seclusion and treated
with neuroleptic medications. Twenty-four hours after admission, he developed a tempera-
ture of104 degrees Fahrenheit, a stiffneck, and severe obtundation. He was transferred to
the general hospital, where medical evaluation revealed cryptococcal meningitis. Mr. D.
was admitted to the medicalfloor, where antibiotic therapy was initiated.
This case illustrates the dangers of preemptive diagnosis — in this instance, of "func-
tional" psychiatric illness. When an HIV-infected patient presents with psychiatric symp-
toms, serious medical illness may well be present. The patient becomes a diagnostic and
treatment dilemma. No one hospital or facility is prepared to meet the challenge of caring
for the patient, and, all too often, the patient is transferred from one facility to another
without proper and thorough evaluation.
Limited Supportfor Individual Patients
HIV patients are often less likely to have family involvement in their care than, for in-
stance, Alzheimer's patients. The stigma of the illness entity contributes to this alienation,
but many of those with the illness are already socially alienated, for example, many in-
travenous drug users and homosexual males. Lacking supports such as family increases
the morbidity (suffering) of the disease. The inability to qualify for health or life insur-
ance because of positive antibody test results is an additional obstacle to obtaining ade-
quate support.
The issue of disability income is also a major concern. It is not currently known to what
extent otherwise asymptomatic seropositives and ARC patients may develop disabling
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cognitive impairment. Some are partially incapacitated, while others are completely
unable to work or to adequately care for themselves.
Because our current programs do not allow for distinctions between partial and full
disability, patients may be forced either to (1) conceal or deny deficits until the condition
becomes so advanced that such efforts are no longer possible, at which time patients must
quit or lose a job and turn to the public welfare system, or (2) go on complete disability
upon receiving an AIDS-related diagnosis, even though they are capable of continuing to
work at the same or at a reduced level.
Because the system fails to make allowance for the subtle distinctions among HIV-in-
fected individuals, it is often impossible for persons to continue working at a reduced
capacity. Income from part-time work often causes discontinuation of disability pay-
ments, even though full-time employment is not possible.
Safety
Public safety is a policy issue, because impaired individuals may hold positions wherein
their neuropsychiatric impairment may jeopardize the welfare of others. Should such
individuals be restricted in their work? Should patients with impairments be allowed to
drive? Currently, the answers to these and related questions are unclear; yet, the safety
issue remains.
Clinical Vignette: Mr. X. , a thirty-two-year-old respiratory therapist, was diagnosed with
ARC after a year oflow-grade temperatures, enlarged lymph nodes, and recurrent oral
thrush. Although hefelt chronically ill, he was able to continue workingfull-time as a
respiratory technician. Formerly married, he had two young children whom he supported
in cooperation with his ex-wife, who workedpart-time as a typist. Mr. X. was without life
or disability insurance at the time ofhis diagnosis. He appliedfor both butfeared that any
investigation into prior conditions would disqualify him.
Mr. X. was referredfor evaluation ofincreasing difficulties with attention, concentra-
tion, and short-term memory. He reported ' 'spacing-out ' ' at work, and on one occasion
mistakenly administered a medication in a dose ten times greater than ordered, not aware
ofthe error until reviewing his paperworkfrom the previous day. Mr. X. felt that his cogni-
tive difficulties reflected his anxiety and depression over his medical condition as well as
his preoccupation with hisfinancial situation.
Neuropsychological testing revealed moderate short-term memory deficits, psychomo-
tor slowing, and difficulty with abstract reasoning. A CATscan ofthe brain was consistent
with a loss ofbrain tissue. Analysis ofcerebrospinalfluid was unremarkable. A diagnosis
ofHIV-related encephalopathy was made. Treatment with methylphenidate, a stimulant
medication, enhanced mental alertness and improved mood, but neuropsychological test
results were unchanged three months later.
Mr. X. joined an ARC support group and began weeklypsychotherapy with a psychia-
trist. He experienced recurrent depression with suicidal ideation, and after several months
stopped responding to methylphenidate. Trials ofseveral antidepressant medications were
discontinued, owing to intolerable side effects. Mr. X. was advised repeatedly that he
should work at a less demandingjob, but he continued to workfor one year, at which time
he developed AIDS. He is currently unemployed and on disability.
This case raises complex treatment and public health issues. Is this patient competent to
continue working at his present job? Who is mandated to make that decision? If he is not
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competent to continue working, should he be considered completely disabled? What will
be the course of his illness? What type of follow-up is indicated for him? What are the
psychological consequences when such an individual stops working yet remains relatively
well for months or years? And what are the consequences for his family and for society?
The problem of intellectually compromised persons in positions of responsibility is not
a new one; substance abuse in the workplace has been of sufficient public concern that
drug testing has been instituted in a number of settings. Unfortunately, there is no simple
diagnostic test for AIDS dementia. Widespread HIV antibody testing would offer no
answer to intellectual functioning; cognitive state can be measured only with neuropsy-
chological testing, a time-consuming and costly endeavor. Furthermore, the results of
such tests must be interpreted in view of the specific demands of the individual's work.
Psychologically, it can be devastating to a productive, self-supporting individual to be
removed from the work force. Many persons on disability become profoundly depressed.
Careful thought must go into developing methods for assessing the intellectual capacity of
infected individuals. Rational, nondiscriminatory policies must evolve to protect the indi-
vidual and society from the untoward effects of cognitive impairment.
Ongoing Psychiatric Care
HIV patients, particularly those with cognitive impairment, are at great risk for psychi-
atric disorders. Common diagnoses in this population include adjustment disorder; major
depression; anxiety; panic disorder; organic affective, delusional, anxiety, and personal-
ity disorder; and dementia.
Individual and group psychotherapy have both been shown to be valuable in the care of
these patients. Furthermore, when appropriate psychiatric services are available, utiliza-
tion of other medical services may decrease.
Clinicians from a variety of disciplines (including social work, psychology, and nurs-
ing) have been working effectively with this population. However, they must always be
closely allied with a psychiatrist who can recognize organic syndromes, prescribe medi-
cation, and refer for neuropsychiatric evaluation when such a referral is appropriate.
Housing
Many patients with dementia lose their housing. Financial depletion may be part of the
cause, but the dementia itself may render these patients unable to live safely without su-
pervision. Such persons would do well in a structured home setting. Currently, there is a
dearth of such placements.
Persons with advanced dementia are often no longer able to perform basic activities of
daily living, such as hygiene and eating. Motor impairments such as paralysis and urinary
incontinence may necessitate intensive nursing care. Such patients will require a total care
facility, such as a hospice, a chronic care hospital, or a nursing home.
Conclusion
We have indicated that a serious feature of HIV infection is its manifold effects on neuro-
logical, cognitive, and psychiatric functioning. These effects are frequent in this popula-
tion and represent a major source of the suffering and disability associated with AIDS.
We may be encouraged that the rate of new HIV infections has slowed in certain popula-
tions; yet, at the same time, we need to soberly recognize the magnitude of the needs of
persons already infected. We now diagnose and treat at an earlier point opportunistic
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infections and malignancies, thereby increasing life expectancy, and, with it, the inci-
dence of clinical neuropsychiatry disorders. It is essential that we prepare ourselves to
optimally care for this patient population.
We cannot rely on the medical and public health systems as they stand today; they are
inadequate for the task of caring for persons who are already ill. Through education and
careful planning, we must prepare ourselves for the increased demands to come. %#
Notes
1
.
D. D. Ho, T. R. Rota, R. T. Schooley, et al. Isolation of HIV from cerebrospinal fluid and neural tis-
sues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
New England Journal of Medicine 1 985;31 5: 1 493- 1 497.
2. M. C. Bach, J. A. Boothby. Dementia associated with human immunodeficiency virus with a
negative ELISA. New England Journal of Medicine 1986;315:891-892.
3. A. Beckett, R Summergrad, T. Manschreck. Symptomatic HIV infection of the CNS in a patient
without clinical evidence of immune deficiency. American Journal of Psychiatry 1987; 144:1342-
1344.
4. B. A. Navia, E. S. Cho, M. L Rosenblum. The AIDS dementia complex: II. neuropathology. Annals
of Neurology 1986;19:525-535.
5. J. Berger. Neurologic complications of human immunodeficiency virus infection. Journal of Post-
graduate Medicine 1987;87:72-79.
6. D. H. Gabuzda, M. S. Hirsch. Neurologic manifestations of infection with human immunodefi-
ciency virus: Clinical features and pathogenesis. Annals of Internal Medicine 1987;107:383-391.
7. C. Petito et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration
in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine
1985;312:874-879.
8. B. A. Navia, B. D. Jordan, R. W. Price. The AIDS dementia complex: I. clinical features. Annals of
Neurology 1986;19:517-524.
9. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired im-
munodeficiency syndrome. Morbidity and Mortality Weekly Report, August 14, 1987;36(15).
10. I. Grant. Neuropsychology and MRI in HIV infected groups. New Research Abstracts ofAmerican
Psychiatric Association Annual Meeting 1987, p. 58.
1 1
.
Committee on a National Strategy for AIDS. Confronting AIDS: Directions for public health, health
care, and research. National Academy Press 1986, Washington, D.C.
12. Laurie Kunches, Massachusetts Department of Public Health, at a meeting of the Massachusetts
Governor's Task Force on AIDS.
119
New England Journal ofPublic Policy
Glossary
Chemotherapeutic
ablation.
Cytomegalovirus.
Immune deficiency that is secondary to drugs given to treat
an underlying disorder.
A distinct virus, but a member of the herpes family ofDNA
viruses.
Embryopathy.
Hepato-splenomegaly.
Histology.
Intravenous
immunoglobulin
.
Lymphadenopathy.
Lymphoid interstitial
pneumonitis.
Mucocutaneous
candidiasis.
A morbid condition in the embryo or in a fetus which may
become apparent after birth.
Enlargement of the liver and spleen.
The science that deals with the minute structure of cells,
tissues, and organs in relation to their function.
A processed blood product with known antibody activity,
given directly into the vein of an individual.
Swollen glands that can be located anywhere in the body.
A particular lung disease that is commonly seen in children
with AIDS. The exact etiology of this condition is not clear
at present.
Yeast infection of the mucous membranes; commonly
known as thrush.
Parotitis.
Pathogen.
Inflammation and swelling of the salivary glands.
Any virus, bacteria, parasite, or other microorganism or
other substance that causes disease.
Pneumonitis.
Sepsis.
An infection of the lung which causes a diffuse change on a
chest x-ray.
An infection of the blood which can be carried to internal
organs via the bloodstream.
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